4-7 Table 1: Adapted from Novo Nordisk and US Food & Drug Administration
#23214, CST, USA), LC3B antibodies (dilution 1:200
This is a fundamentally different strategy than administering synthetic growth hormone, and it leans on the same machinery your body has always used to regulate GH
Estimated to be valued at $757.06 billion this year, the market is projected to reach 1,630.73 billion by 2033, according to Nova One Advisor
Serious but Rare Side Effects These side effects are less common but require immediate medical attention: Pancreatitis: Wegovy can, in rare cases, cause inflammation of the pancreas
UV Shield: Reduces the harmful effects of ultraviolet radiation